John Libbey Eurotext

Environnement, Risques & Santé

Biological and chemical-ozone oxidation of emerging micropolluants in wastewater treatment plants Ahead of print

Figures

  • Figure 1
  • Figure 2
  • Figure 3

Tables

Authors
1 SUEZ Treatment Infrastructure, SUEZ Int.
183, avenue du 18 Juin 1940
92500 Rueil-Malmaison
France
2 Équipe TRACES, ISA UMR 5280
5, rue de la Doua
69900 Villeurbanne
France
3 ENTPE, INRA USC 1358, CNRS UMR 5023 LEHNA
Rue Maurice-Audin
69518 Vaulx-en-Velin cedex
France
* Tirés à part

Pharmaceuticals are found in significant quantities in municipal wastewater, probably because of their incomplete biotransformation by human or animal metabolization. They are not completely eliminated through conventional wastewater treatment and are subsequently released into the aquatic environment. More advanced treatment is required for the effective reduction of the quantity of pharmaceuticals entering the environment. Among the available technical treatments, tertiary ozonation has proved an economically feasible and highly effective way of removing a wide range of contaminants. Like other oxidative treatments, ozonation leads to major changes in the water composition. Consequently, it is important to evaluate the toxic potential of the treated effluent through relevant ecotoxicological end points.

This pilot study took place at the Bellecombe WWTP (France). A mixture of municipal and hospital wastewater was treated by conventional activated sludge (CAS) followed by tertiary ozonation at three transferred ozone doses ranging from 0.45 to 2.30 mg O3/mg DOC with a hydraulic contact time of 5 minutes. To characterize the removal efficiencies of both CAS and CAS with tertiary ozonation, 12 pharmaceuticals were tested. Endocrine disruption tests were conducted to assess the toxic potential of the effluents.

The overall elimination yields achieved by CAS were 48% with a high standard deviation (above 18%). The addition of tertiary ozonation greatly improved the global removal to 92% (± 4%) for an average transferred ozone dose of 0.45 mg O3/mg DOC. Increasing the ozone dose to 1.30 mg O3/mg DOC significantly enhanced the removal of the pharmaceuticals, with kO3 below 105 M-1·s-1. In addition, estrogenic, androgenic, and glucocorticoid endocrine disruption were all reduced in the ozonation stage.

Ozonation proved to be highly effective in removing pharmaceuticals at low ozone doses, while simultaneously reducing the potential of endocrine disruption activities compared with biological treatment by conventional activated sludge.